Osteoporosis is a condition in which a decrease in the density of bones weakens the bones, making breaks (fractures) likely.
Aging, estrogen deficiency, low vitamin D or calcium intake, and certain disorders can decrease the amounts of the components that maintain bone density and strength.
Osteoporosis may not cause symptoms until a bone fracture occurs.
Fractures can occur with little or no force and may occur after a minor fall.
Although fractures are often painful, some fractures of the spine do not cause pain but can still cause deformities.
Doctors diagnose people at risk by testing their bone density.
Osteoporosis can usually be prevented and treated by managing risk factors, ensuring adequate calcium and vitamin D intake, engaging in weight-bearing exercise, and taking bisphosphonates or other drugs.
Bones contain minerals, including calcium and phosphorus, which make them hard and dense. To maintain bone density (or bone mass), the body requires an adequate supply of calcium and other minerals and must produce the proper amounts of several hormones, such as parathyroid hormone, growth hormone, calcitonin, estrogen, and testosterone. An adequate supply of vitamin D is needed to absorb calcium from food and incorporate it into bones. Vitamin D is absorbed from the diet and also manufactured in the skin using sunlight (see Vitamin D).
So that bones can adjust to the changing demands placed on them, they are continuously broken down and reformed. This process is known as remodeling (see Bones). In this process, small areas of bone tissue are continuously removed and new bone tissue is deposited. Remodeling affects the shape and density of the bones. In youth, the bones grow in width and length as the body grows. In later life, bones may sometimes enlarge in width but do not continue to grow longer.
Loss of Bone Density in Women
In women, bone density (or mass) progressively increases until about age 30, when bones are at their strongest. After that, bone density gradually decreases. The rate of bone loss accelerates after menopause, which occurs on average around age 51.
Because more bone is formed than is broken down in the young adult years, bones progressively increase in density until about age 30, when they are at their strongest. After that, as breakdown exceeds formation, bones slowly decrease in density. If the body is unable to maintain an adequate amount of bone formation, bones continue to lose density and may become increasingly fragile, eventually resulting in osteoporosis.
Types of Osteoporosis
About 8 million women and 2 million men in the United States have osteoporosis. There are two main types of osteoporosis:
Primary osteoporosis occurs spontaneously, and secondary osteoporosis is caused by another disorder or drug.
More than 95% of osteoporosis in women and probably about 80% in men is primary. Most cases occur in postmenopausal women and in older men.
A major cause of osteoporosis is a lack of estrogen, particularly the rapid decrease that occurs at menopause. Most men over 50 have higher estrogen levels than postmenopausal women, but these levels also decline with aging, and low estrogen levels are associated with osteoporosis in both men and women. Estrogen deficiency increases bone breakdown and results in rapid bone loss. In men, low levels of male sex hormones also contribute to osteoporosis. Bone loss is even greater if calcium intake or vitamin D levels are low. Low vitamin D levels result in calcium deficiency, and increased activity of the parathyroid glands causes the glands to release too much parathyroid hormone (see What Is Hyperparathyroidism?), which can also stimulate bone breakdown. For unknown reasons, bone production also decreases.
A number of other factors, such as certain drugs, tobacco use, heavy alcohol use, a family history of osteoporosis (for example, if a person's parents have had hip fractures), and small body stature, increase the risk of bone loss and the development of osteoporosis in women. These risk factors are also important in men.
Less than 5% of osteoporosis in women and about 20% in men is secondary.
Examples of disorders that may cause secondary osteoporosis are chronic kidney disease and hormonal disorders (especially Cushing disease, hyperparathyroidism, hyperthyroidism, hypogonadism, high levels of prolactin, and diabetes mellitus). Certain types of cancer, such as multiple myeloma, can cause secondary osteoporosis, as can other chronic diseases such as rheumatoid arthritis. Examples of drugs that may cause secondary osteoporosis are progesterone, corticosteroids, thyroid hormones, certain chemotherapy drugs, and anticonvulsants. Cigarette smoking can also cause or contribute to secondary osteoporosis. Excessive alcohol or caffeine consumption and cigarette smoking may worsen preexisting osteoporosis but are unlikely to cause it.
Risk Factors for Primary Osteoporosis
Family members with osteoporosis
A diet that is low in calcium and vitamin D
White or Asian race
Excessive alcohol or caffeine consumption
Idiopathic osteoporosis is a rare type of osteoporosis. The word idiopathic simply means that the cause is unknown. This type of osteoporosis occurs in premenopausal women, in men under age 50, and in children and adolescents who have normal hormone levels, normal vitamin D levels, and no obvious reason to have weak bones.
Symptoms of Osteoporosis
At first, osteoporosis causes no symptoms because bone density loss occurs very gradually. Some people never develop symptoms. However, when osteoporosis causes bones to break (fracture), people may have pain depending on the type of fracture. Fractures tend to heal slowly in people who have osteoporosis and may lead to deformities such as curvature of the spine.
In long bones, such as the bones of the arms and legs, the fracture usually occurs at the ends of the bones rather than in the middle. The bones of the spine (vertebrae) are particularly at risk of fracture due to osteoporosis. These fractures usually occur in the middle to lower back.
Vertebral compression fractures (fractures of spinal vertebrae) may occur in people who have any type of osteoporosis. These fractures are the most common osteoporosis-related fractures. The weakened vertebrae may collapse spontaneously or after a slight injury. Most of these vertebral compression fractures do not cause pain. However, pain can develop, usually starting suddenly, staying in a particular area of the back, and worsening when a person stands or walks. The area may be tender. Usually the pain and tenderness begin to go away gradually after 1 week. However, lingering pain may last for months or be constant. If several vertebrae break, an abnormal curvature of the spine (a dowager's hump) may develop, causing muscle strain and soreness as well as deformity.
Bones in other parts of the body may fracture, often because of a relatively minor strain or fall (called fragility fractures). One of the most serious fractures is a hip fracture, a major cause of disability and loss of independence in older people. Wrist fractures occur often, especially in people with postmenopausal osteoporosis.
People who have had one fracture in which osteoporosis had been a factor are at much higher risk of having more such fractures.
Did You Know...
People who have had one osteoporosis-related fracture are at much higher risk of having more of these fractures.
Diagnosis of Osteoporosis
Bone density testing
Vitamin D level
Tests for causes of secondary osteoporosis
A doctor may suspect osteoporosis in the following people:
All women age 65 or older
Women between menopause and age 65 who have risk factors for osteoporosis
All men and women who have had a previous fracture caused by little or no force, even if the fracture occurred at a young age
Adults age 65 or older who have unexplained back pain or loss of at least 1.2 inches (about 3 centimeters) of body height
People whose bones appear thin on x-rays or who have vertebral compression fractures on x-rays
People who are at risk of developing secondary osteoporosis
If osteoporosis is suspected and people have not had x-rays, doctors may do them. Certain findings on x-rays suggest osteoporosis, but the diagnosis of osteoporosis is confirmed by bone density testing.
Bone density testing
Bone density testing can be used to detect or confirm suspected osteoporosis, even before a fracture occurs. A number of rapid screening techniques are available to measure bone density at the wrist or the heel. The most useful test, however, is dual-energy x-ray absorptiometry (DXA), which measures bone density at the sites at which major fractures are likely to occur: the spine and hip. This test is painless, involves very little radiation, and can be done in about 10 to 15 minutes. It may be useful for monitoring the response to treatment as well as for making the diagnosis. DXA may also reveal osteopenia, a condition in which bone density is decreased but not as severely as in osteoporosis. Osteopenia can also increase the risk of fractures.
Blood tests may be done to measure calcium and vitamin D levels. Further testing may be needed to rule out treatable conditions that might lead to osteoporosis. If such a condition is found, the diagnosis is secondary osteoporosis.
Prevention of Osteoporosis
Prevention of osteoporosis is generally more successful than treatment because it is easier to prevent loss of bone density than to restore density once it has been lost. Osteoporosis prevention involves
Managing risk factors (for example, quitting smoking and avoiding excess alcohol and caffeine use)
Consuming adequate amounts of calcium and vitamin D
Engaging in weight-bearing exercise (such as walking, climbing stairs, or weight training)
Taking certain drugs (for some people)
Certain measures can help prevent fractures. Many older people are at risk of falls because of poor coordination, poor vision, muscle weakness, confusion, and use of drugs that cause light-headedness when people stand or cause confusion. Modifying the home environment for safety (see Prevention) and working with a physical therapist to develop an exercise program can help. Strengthening exercises may help improve balance.
Did You Know...
Most older women need to take a supplement of vitamin D that supplies 800 to 1,000 international units (IUs) per day.
Treatment of Osteoporosis
Calcium and vitamin D
Treatment of fractures
Osteoporosis treatment involves ensuring adequate intake of calcium and vitamin D and engaging in weight-bearing exercises. All people being treated need to take drugs. When treating people who have osteoporosis, doctors also manage conditions and risk factors that can make osteoporosis worse.
Calcium and vitamin D
Consuming an adequate amount of nutrients, particularly calcium and vitamin D, is helpful, especially before maximum bone density is reached (around age 30) but also after this time. Vitamin D helps the body absorb calcium.
All men and women should consume at least 1,000 milligrams of calcium each day. Postmenopausal women, older men, children who are going through puberty, and women who are pregnant or breastfeeding may need to consume 1,200 to 1,500 milligrams each day. Foods rich in calcium include dairy products (such as milk and yogurt), certain vegetables (such as broccoli), and nuts (such as almonds).
Dietary sources of calcium are preferred to supplements (see Table Amount of Calcium in Some Foods). However, if people cannot consume the recommended amounts by diet alone, they need to take supplements. Many calcium preparations are available, and some include supplemental vitamin D. The most common supplements are calcium carbonate or calcium citrate. Calcium citrate supplements should be taken by people who take a proton pump inhibitor such as omeprazole (which is used to reduce stomach acid production) or who have had gastric bypass surgery.
Amount of Calcium in Some Foods
Amount of Calcium (in milligrams)
Almonds (toasted, unblanched)
Bok choy (raw, shredded)
Bread (calcium fortified*)
150 to 200
Bread (whole wheat)
Buttermilk (low fat)
Carnation® powder drink mix
Cereal (calcium fortified*)
100 to 1,000
Cream cheese (regular)
Figs (dried, uncooked)
Frozen yogurt (vanilla, soft serve)
Hard cheese (such as Cheddar or Jack)
Hot cocoa (calcium fortified*)
Ice cream (vanilla)
Kale (fresh, cooked)
Kale (raw, chopped)
Nonfat dry milk powder
100 to 150
Orange juice (calcium fortified*)
Reduced-fat milk (2%)
Salmon (canned with bones)
Sardines (canned in oil with bones)
Sesame seeds (whole-roasted)
Sour cream (reduced fat, cultured)
Soy milk (calcium fortified*)
Tofu (firm and made with calcium sulfate)
Tofu (soft and made with calcium sulfate)
Turnip greens (fresh or boiled)
Yogurt (plain, low fat)
*Calcium-fortified foods are foods with added calcium.
People should consume 800 to 1,000 international units (IUs) of supplemental vitamin D each day. People who have vitamin D deficiency may need even higher doses. Sometimes doctors check the level of vitamin D in the blood to determine how much supplemental vitamin D should be taken. The most common food source is fortified foods, mainly cereals and dairy products. Vitamin D is also present in fish liver oils and fatty fish. Supplemental vitamin D is usually given as cholecalciferol, the natural form of vitamin D, but ergocalciferol, the synthetic plant-derived form, is also given.
Weight-bearing exercise, such as walking and stair-climbing, increases bone density. Exercises that do not involve weight bearing, such as swimming, do not increase bone density but do increase core strength and balance and reduce the risk of falls. Most experts recommend about 30 minutes of weight-bearing exercise daily. A physical therapist can develop a safe exercise program for people and demonstrate how to safely perform daily activities to minimize the risk of falls and spine fractures.
Curiously, in premenopausal women, high levels of exercise, such as those maintained by athletes, can actually cause a small reduction in bone density because such exercise suppresses the production of estrogen by the ovaries.
Most of the same drugs are used for prevention and treatment.
Bisphosphonates (alendronate, risedronate, ibandronate, and zoledronic acid) are useful in preventing and treating all types of osteoporosis and are usually the first drugs used. Bisphosphonates have been shown to increase bone density in the spine and hips and reduce the risk of fractures. Alendronate and risedronate can be taken by mouth (orally). Zoledronic acid can be given by vein (intravenously). Ibandronate can be taken orally or intravenously.
An oral bisphosphonate must be swallowed on an empty stomach with a full glass of water (8 ounces) after arising for the day. No other food, drink, or drug should be consumed for the next 30 to 60 minutes because food in the stomach may decrease the absorption of the drug. Because oral bisphosphonates can irritate the lining of the esophagus, the person must not lie down for at least 30 minutes (60 minutes for ibandronate) after taking a dose. Certain people, including those who have difficulty swallowing, gastrointestinal symptoms (for example, heartburn or nausea), and certain disorders of the esophagus or stomach, should not take the bisphosphonates orally. These people can be given ibandronate or zoledronic acid intravenously. In addition, the following people should not take bisphosphonates:
Women who are pregnant or nursing
People who have low levels of calcium in the blood
People who have severe kidney disease
At this time, doctors do not know how long people should take bisphosphonates. Most people need to take these drugs for 3 to 5 years, and some people may need to take them for up to 10 years. The determination of how long taking the drugs is likely to be helpful is made by the doctor and is based on a person's medical condition and risk factors for fracture. After stopping, doctors usually do periodic tests to determine whether bone mass is decreasing. If bone mass is decreasing, treatment with a bisphosphonate or another drug may be restarted.
Osteonecrosis of the jaw is a rare condition that has occurred in some people who take bisphosphonates. In this condition, the jaw bone breaks down, particularly in people who have had extensive dental work or injury, take bisphosphonates intravenously, who have had radiation therapy to the head and neck to treat cancer, or a combination are at highest risk. However, it is not truly clear whether bisphosphonates cause osteonecrosis of the jaw and, if they do, which particular drugs are most likely to cause it. There is no evidence that stopping bisphosphonates before having dental work helps. The risk of developing osteonecrosis of the jaw is exceptionally low in people taking bisphosphonates, and the likely benefits in treating to prevent bone fractures usually far outweigh the potential harms.
Long-term use of bisphosphonates may increase the risk of developing unusual fractures of the thighbone (femur). However, bisphosphonates, when used as prescribed, prevent many more fractures than they may cause.
Calcitonin, which inhibits the breakdown of bone, is another drug used for treatment but not frequently. Calcitonin has not been shown to reduce fracture risk, but it can help relieve pain caused by vertebral fractures. Calcitonin is usually taken by nasal spray. Its use can decrease blood levels of calcium, so these levels must be monitored.
Hormonal therapy (for example, with estrogen) helps maintain bone density in women and can be used for prevention or treatment. This therapy is most effective when started within 4 to 6 years after menopause, but starting it later can still slow bone loss and reduce the risk of fractures. However, because the risks of hormonal therapy exceed its benefits for most women, hormonal therapy is usually not the treatment option used. Decisions about using estrogen replacement therapy after menopause are complex (see Hormone Therapy for Menopause).
Raloxifene is an estrogen-like drug that may be useful in preventing and treating bone loss, but it does not have some of estrogen's negative side effects. Raloxifene is used in people who cannot or prefer not to take bisphosphonates. Raloxifene can reduce the risk of vertebral fractures and may reduce the risk of invasive breast cancer.
Men do not benefit from estrogen but may benefit from testosterone replacement therapy if their testosterone level is low.
A synthetic form of parathyroid hormone called teriparatide can be injected daily in small amounts. Teriparatide increases the formation of new bone, increases bone density, and decreases the likelihood of fractures. This therapy is used in some people who
Develop marked bone loss or new fractures while being treated with a bisphosphonate
Cannot take bisphosphonates
Have unusually severe osteoporosis or many fractures (particularly vertebral fractures)
Have osteoporosis caused by corticosteroids
Denosumab is a newer drug. It is an alternative to other drugs used to treat osteoporosis. Denosumab is given as an injection under the skin in a doctor's office two times a year.
Treatment of pain and fractures
Back pain resulting from a vertebral compression fracture should be treated with pain relievers and sometimes heat and massage and/or supportive devices (such as back braces). People may be given calcitonin to decrease the pain caused by vertebral fractures. Exercises to strengthen muscles in the back may help relieve chronic back pain. People should usually avoid bed rest and heavy lifting. People should do weight-bearing exercises.
Fractures resulting from osteoporosis must be treated. For hip fractures, usually the joint is stabilized and often part or all of the hip is replaced surgically (see Hip replacement). Surgery may be needed for a wrist fracture, or the wrist may need to be placed in a cast.
A collapsed vertebra can be repaired by a procedure called vertebroplasty. In this procedure, which takes about an hour for each vertebra, a material called methyl methacrylate (MMA)—an acrylic bone cement—is injected into the collapsed vertebra, helping to relieve pain and reduce deformity. Kyphoplasty is a similar procedure, in which an orthopedic balloon is used to expand the vertebra back to its normal shape before the injection of the MMA. With vertebroplasty and kyphoplasty, deformity may be reduced in the MMA-injected bone, but the risk of fractures in adjacent bones in the spine or ribs does not decrease and may even increase. Other risks may include rib fractures, cement leakage, and possibly heart or lung problems. When these procedures should be done has not been clearly determined.
Doctors typically provide any helpful treatments for and monitor people who have fractures to be sure their osteoporosis is adequately treated. People who have fractures and who have risk factors for osteoporosis but who have not yet had a fracture or developed osteoporosis should take preventive measures to avoid its development.